Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers

Phase 1 Completed 49 enrolled Celltrion

RandomizedCrossoverOpen-labelTreatment

Summary

This is a randomized, open, single-dose, crossover-design, phase I study to evaluate the pharmacokinetics and safety after co-administration of L03RD1 and L03RD2 or administration of CT-L03 in healthy volunteers.

Timeline

Start: 2025-08-18
Primary completion: 2025-10-03
Completion: 2025-10-23

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	CT-L03	Unknown	—	—
Subject	L03RD1	Unknown	—	—
Subject	L03RD2	Unknown	—	—

Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers

Summary

Timeline

Drugs

Indications